Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Roy Castle Lung Cancer Foundation | Researchclopedia

Back to institutions

Roy Castle Lung Cancer Foundation

Liverpoolnonprofit

352

Works

61,106

Citations

110

h-index

Top Research Topics

Lung Cancer Treatments and Mutations Lung Cancer Diagnosis and Treatment RNA modifications and cancer

Top Researchers

George Davey Smith University of Bristol

4,318 works439,868 citationsh-index: 276

Recent Research

Genes associated with genetic and rare lung diseases and the risk of lung cancer

Albert Rosenberger,Heike Bickeböller,et al.

20260 citations

Global Cancer Incidence and Screening

Epigenetics and DNA Methylation

Genetic factors in colorectal cancer

Radiomics and Machine Learning in Medical Imaging

Air Quality and Health Impacts

Cancer-related Molecular Pathways

Cancer Genomics and Diagnostics

Genetic Associations and Epidemiology

Occupational and environmental lung diseases

Frances R. Balkwill Queen Mary University of London

742 works66,364 citationsh-index: 105

Jolanta Lissowska

745 works64,261 citationsh-index: 114

Peter J.F. Snijders

539 works58,686 citationsh-index: 108

David J. Adams Wellcome Sanger Institute

965 works57,060 citationsh-index: 113

Paula Williamson University of Liverpool

892 works53,975 citationsh-index: 108

Implementation of the NHS England Lung Cancer Screening Programme over 5 years

Richard W. Lee,Arjun Nair,et al.

20261 citations

Evaluating eight smoking metrics for modelling survival in non-small cell lung cancer

Andrew CL Lam,Yao Ting Li,et al.

20260 citations

Occupational exposure to chlorinated solvents and lung cancer: results of the SYNERGY case–control study

Wenxin Wan,Roel Vermeulen,et al.

20260 citations

Radiotherapy patterns and factors associated with pneumonitis in PACIFIC-R, a real-world study of patients with unresectable stage III non-small-cell lung cancer treated with durvalumab after chemoradiotherapy

Andrea R. Filippi,Bar J,et al.

20260 citations

Real-world 5-year outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC

N. Girard,J. Bar,et al.

20260 citations